Abstract

Multiple acyl-CoA dehydrogenase deficiency (MADD) is a clinically heterogeneous disorder mainly caused by mutations in the genes for electron transfer flavoprotein (ETF) and ETF-ubiquinone oxidoreductase (ETF-QO). Mutations in ETFDH, which encodes for ETF-QO has been associated with myopathic form of CoQ10 deficiency, riboflavin-responsive MADD, and riboflavin-nonresponsive MADD, although the underlying mechanism of these different phenotypes is still unclear. We identified three novel mutations in ETFDH in four Taiwanese riboflavin-responsive MADD patients from three unrelated families.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call